Abstract
We would like to thank Wang et al. [1] for their interest in our study: “Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience” [2]. Coagulation derangements, mostly seen as venous or arterial thromboembolism, have been associated with poor outcomes in COVID-19 and by now are considered as a common manifestation of this disease, along with cardiovascular involvement [3]. Indeed, an actual COVID-19 induced coagulopathy has been identified, including an early local hypercoagulable state followed by a cytokine storm.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
